ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
113.29
-4.62 (-3.92%)
Dec 16, 2025, 9:32 AM EST - Market open
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $9.26 billion as of December 16, 2025. Its market cap has increased by 1,648.93% in one year.
Market Cap
9.26B
Enterprise Value
8.65B
1-Year Change
1,648.93%
Ranking
Category
Stock Price
$113.29
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $9.26B, an increase of 4,007.49%. That is a compound annual growth rate of 42.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 9.26B | 1,989.28% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | 582.13M | 95.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.06B |
| Johnson & Johnson | 516.00B |
| AbbVie | 401.99B |
| UnitedHealth Group | 308.98B |
| AstraZeneca | 282.48B |
| Novartis AG | 258.61B |
| Merck & Co. | 248.85B |
| Abbott Laboratories | 223.39B |